B2M and chronic kidney disease: This syndrome can also be observed in end-stage renal diseases patients undergoing peritoneal dialysis and even in patients with chronic renal failure before the initiation of dialytic therapy, suggesting that HD is not a direct cause, but that accumulation of β2m or some β2m-associated molecules in the body is a common pathogenesis [7].